Reversibility of regorafenib effects in hepatocellular carcinoma cells

Author： D’Alessandro Rosalba   Refolo Maria   Lippolis Catia   Messa Caterina   Cavallini Aldo   Rossi Roberta   Resta Leonardo   Carlo Antonio   Carr Brian  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.72, Iss.4, 2013-10, pp. : 869-877

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells

By            

Molecular Medicine Reports, Vol. 5, Iss. 5, 2012-01 ,pp. : 1295-1298

Spandidos Publications

Access to resources Recommend Favorite

Synergistic anticancer effects of curcumin and resveratrol in Hepa1-6 hepatocellular carcinoma cells

By Du Qin   Hu Bing   An Hong-Mei   Shen Ke-Ping   Xu Ling   Deng Shan   Wei Meng-Meng  

Oncology Reports, Vol. 29, Iss. 5, 2013-05 ,pp. : 1851-1858

Spandidos Publications

Access to resources Recommend Favorite

Anti-proliferative effects of anandamide in human hepatocellular carcinoma cells

By                    

Oncology Letters, Vol. 4, Iss. 3, 2012-01 ,pp. : 403-407

Spandidos Publications

Access to resources Recommend Favorite

Suppressive effects of 3-bromopyruvate on the proliferation and the motility of hepatocellular carcinoma cells

By            

Oncology Reports, Vol. 35, Iss. 1, 2016-01 ,pp. : 59-63

Spandidos Publications

Access to resources Recommend Favorite

Effects of cordycepin on HepG2 and EA.hy926 cells: Potential antiproliferative, antimetastatic and antiangiogenic effects on hepatocellular carcinoma

By            

Oncology Letters, Vol. 7, Iss. 5, 2014-01 ,pp. : 1556-1562

Spandidos Publications

Access to resources Recommend Favorite